November 18, 2026 · Blood · DOI: 10.1182/blood.2026035669

Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway.

Listen to this summary

This study asks how CAR-T-associated inflammation leads to blood-brain barrier (BBB) breakdown and neurotoxicity (ICANS), a mechanism that has remained poorly understood. The authors found that IDO1 activity was elevated in ICANS patients and in a CAR-T mouse model, and that IDO1 in brain endothelial cells drove barrier loss by shifting kynurenine metabolism toward KYNU-derived anthranilic acid, which suppresses Wnt/β-catenin-dependent tight junction maintenance. Pharmacological inhibition or endothelial-specific silencing of IDO1 restored barrier integrity and improved neurological outcomes, suggesting endothelial IDO1 as a therapeutic target for CAR-T neurotoxicity.

Wanying Zhang, Zhaozhao Chen, Zi Wang, Jianghua Wu, Zihan Gong, Wenjing Luo, Chenggong Li, Yinqiang Zhang, Yingying Li, Zhong Wu, Yun Kang, Peiru Li, Jinhui Shu, Liman Su, Hekuan Huang, Anqi Ren, Fen Zhou, Heng Mei

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play